In the era of personalized cancer treatment, large-scale genetic analysis of tumors is considered to be key for a better selection of patients for an appropriate anticancer therapy. Owing to this ...
All the patients analyzed in this study have been seen in the context of a genetic session and fulfilled at least one the following criteria: (i) breast cancer before the age of 36, (ii) medullary ...
ESMO's recommendation is therefore that large panels of genes can be used if they generate an acceptable increase in the overall cost, drugs included. Considering that the results of NGS panels could ...
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today released cost analysis results and health economic ...
AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced publication of a study ...
NGS has had a big impact on basic research, now the revolutionary technology is changing clinical practices. Sequencing technology has come a long way. Next-generation sequencing (NGS) has ...
Lugano, Switzerland, 25 August 2020 - Recommendations on the use of next-generation sequencing (NGS) for patients with metastatic cancers are being launched today [25 August] by the European Society ...
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today released cost analysis results and health economic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results